A prospective study to evaluate the histopathologic pattern pf carcinoma of cervix and to find out the incidence rate and most common type of the carcinoma of cervix

Authors

  • Uma
  • Nanditha HS
  • Rashmi SP

DOI:

https://doi.org/10.47750/pnr.2022.13.S09.330

Keywords:

Carcinoma Cervix, Squamous Cell Carcinoma, Large cell non keratinizing.

Abstract

Objectives: To study histopathologic pattern pf carcinoma of cervix and to find out the incidence rate and most common type of the carcinoma of cervix.
Material and Method: This study was undertaken in the department of pathology over a period of 2 years from June 2012 to June 2014. All Hysterectomy specimens and cervical biopsies were processed routinely and paraffin sections were taken and stained with Haematoxylin and Eosin (H&E) for microscopic examination. Tumours of the cervix were classified and studied according to WHO classification.
Results: Women in the study were in the age range of 31-50 years and had no education, with only 24.67% having primary education. The most common presenting complaint in 84% of cases was leucorrhoea. 56% (421) of the cases were reported as Chronic Non-Specific cervicitis followed by a significant number of cases presenting as Carcinoma Cervix (30%). There were 227 cases of Carcinoma cervix. Squamous cell Carcinomas accounted for 223 cases (98.24%). There were 3 cases of Adenocarcinoma (1.32%), and a single case of adenosquamous carcinoma. Histopathologic variants of SCC include large cell Keratinizing 76 cases (34.08%), Large cell non-Keratinizing 118 cases (52.92%) and small cell type 29 cases (13%).
Conclusion: Incidence of squamous cell carcinoma was more as compared to adenocarcinoma. Among Squamous Cell Carcinoma, Large cell non keratinizing type was the predominant type.

Downloads

Published

— Updated on 2022-11-25

Issue

Section

Articles

How to Cite

A prospective study to evaluate the histopathologic pattern pf carcinoma of cervix and to find out the incidence rate and most common type of the carcinoma of cervix. (2022). Journal of Pharmaceutical Negative Results, 2757-2762. https://doi.org/10.47750/pnr.2022.13.S09.330